ProfileGDS5822 / ILMN_2837195
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 93% 84% 84% 93% 86% 87% 82% 88% 91% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1834.893
GSM1276600PDAC Late Ablation Control 2242.284
GSM1276601PDAC Late Ablation Control 3299.284
GSM1276602PDAC Late Ablation 1804.993
GSM1276603PDAC Late Ablation 2303.486
GSM1276604PDAC Late Ablation 3362.287
GSM1303940PDAC Late Ablation_anti-CTLA4 117182
GSM1303941PDAC Late Ablation_anti-CTLA4 2483.388
GSM1303942PDAC Late Ablation_anti-CTLA4 3682.991